AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, direct reimbursement under Medicare Program, and annual payment updates. Communication with the Office of the Inspector General regarding Conflicts of Interest for Compendia recognized by Medicare. Support for Grassley/Carper Amendment #7 to the SGR Repeal and Medicare Beneficiary Access Act of 2013 (S. 1871), which would list pharmacists as providers within Accountable Care Organizations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the FDA on the REMS program. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS GENTILE | — |
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KASEY THOMPSON | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.